DFDS A/S
| Company announcement no. 11/2021 |
In compliance with Article 19 of EU Regulation no. 596/2014, transactions are reported related to shares in DFDS A/S made by executives in DFDS and/or persons closely associated with them.
The transactions of Torben Carlsen, CEO, are reported in the table below.
| Name | Torben Carlsen |
| Position | CEO |
| Issuer | DFDS |
| ID code | DK 0060655629 |
| Initial notification/ Amendment | Initial notification |
| Instrument | Shares |
| Transactions |
|
| Transaction date | 23-24 February 2021 |
| Price and volume |
|
| Transaction values |
|
| Market | XCSE, Nasdaq Copenhagen |
The Executive Board’s holding of shares in DFDS is available from this link
Contact
Torben Carlsen, CEO, +45 33 42 32 01
Karina Deacon, CFO, +45 33 42 33 42
Søren Brøndholt Nielsen, IR, +45 33 42 33 59
Nicole Seroff, Communications, +45 31 40 34 46
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Cabka N.V.23.10.2025 08:50:00 CEST | Press release
From Waste to Value: New CNBC Feature Highlights Cabka’s Sustainability Innovation in Action
Recordati23.10.2025 08:32:37 CEST | Press release
RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
Vaisala Group23.10.2025 08:00:54 CEST | Press release
Vaisala Corporation Interim Report January–September 2025: Strong sales and profitability in the third quarter
Tallink Grupp23.10.2025 08:00:42 CEST | Press release
AS Tallink Grupp Unaudited Consolidated Interim Report for the Q3 2025
Pharming Group N.V.23.10.2025 08:00:08 CEST | Press release
Pharming Group to report third quarter 2025 financial results and provide business update on November 6
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
